From: "James Meiskin"
To:"
Subject: FW: Confidential
Date: Wed, 21 May 2014 13:23:58 +0000
Attachments: DaCart_Presentation.pptx
Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow morning, and I
felt that it could be beneficial and timely for you to further learn about this opportunity if there was
interest on your end. Please take a moment to review the attached material. and let me know if you
would like to meet while David is in NYC. Best Regards, James
Dear James,
Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money
Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to
develop a variety of technologies that are of interest to their country. For their investment they get
commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this
is a major source of capital to start a series of companies that have great potential as therapeutic technologies,
and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights
that are valuable to us at "half price".
Over the next several years our plan is to identify seven/eight technologies that are worthy of development.
RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and
OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow
is attached)
So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to
consider the idea as something they might want to implement. My belief is that there is more money in NYC,
seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe
that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment
ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are
talking $150M over a five year horizon.
Best, David
David W. Carter
EFTA00369254
President—DaCart Capital LLC
EFTA00369255